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The ethical review of research on adolescent sexual behavior is challenging. Investigators 
and institutional review boards (IRBs) alike struggle with pediatric risk categorizations for 
research on sexual health and other sensitive topics, resulting in variable categorization of 
the same protocols among IRBs, and delays in approvals.1 In pediatric research, IRB 
decisions can vary greatly, not only from institution to institution, but also between different 
review boards within the same institution.2 These variations suggest that the regulations and 
laws governing adolescent participation in research are neither uniformly understood nor 
applied.3 This is not surprising, given the complex interplay of regulations and laws related 
to research consent for children and adolescents who are not legal adults. “Children” are 
defined in U.S. research regulations as “persons who have not attained the legal age for 
consent to treatments or procedures involved in the research, under the applicable law of the 
jurisdiction in which the research will be conducted.”4 Moreover, the regulations reference 
clinical standards of care in the definition of minimal risk: “the probability and magnitude of 
harm or discomfort anticipated in the research are not greater in and of themselves than 
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those ordinarily encountered in daily life or during the performance of routine physical or 
psychological examinations or tests.”5 The definition of “children” requires investigators 
and IRBs to be knowledgeable not only about federal regulations but also about complex 
state health care consent laws6 regarding adolescent sexual health and reporting 
requirements. An example of the variability in state law is that while all states allow minor 
consent for services for sexually transmitted infections (STIs), only a subset cover minor 
consent for pregnancy services.7
Because of the enormous developmental changes in cognitive capacity, family and personal 
relationships, and health risk behaviors across adolescence, procedures that are best 
practices for older adolescents (such as 16- and 17-year-olds) may not be best practices for 
very young adolescents (11- and 12-year-olds), and investigators and IRBs must be aware of 
developmental differences across adolescence as laid out by professional guidelines.8 As the 
leading causes of adverse health outcomes among adolescents reflect certain risk behaviors, 
much adolescent research covers sensitive and stigmatizing topics, such as sexual behavior 
and substance use, increasing the difficulty of accurately assessing risks. Studies show that 
IRBs frequently overestimate risk on sensitive topics and behavioral research9 and may be 
less likely to consider a waiver of parental consent for these types of research, even if the 
study objectively falls within the requirements for this exception.10 While data exist on 
variability in the outcome of IRB evaluation of adolescent sexual behavior research, little is 
known about the process of that evaluation. Thus, the main objective of this study was to 
examine factors that influence how pediatric investigators, IRB members, and IRB staff 
members categorize risk in adolescent sexual behavior research and assess whether the IRB 
should approve such research.
Study Context and Methods
Our study site was a university in Indiana where protocols to conduct research with 
adolescents are evaluated by one of seven university-wide IRBs. Five of those IRBs (four 
biomedical and one behavioral) are located at the urban medical campus, one is located at 
the main university campus, and one is for expedited research. IRB members, IRB staff 
members, and any investigators who submitted protocols involving minor adolescents (ages 
11 to 17 years) were invited via email to participate in an online survey about their 
knowledge, attitudes, and approach to research with vulnerable populations, including 
adolescents. Individuals received three email reminders and one telephone call. The response 
rate was 52%, consistent with similar online surveys.11
Participants read a brief hypothetical research scenario of a single, anonymous survey of 11- 
to 14-year-olds about their sexual behaviors, including oral, vaginal, and anal sex. This 
scenario was chosen as a representation of a common adolescent research protocol, similar 
to questions in the Centers for Disease Control and Prevention’s Youth Risk Behavior 
Surveillance System. The investigator in the scenario was planning to obtain parental 
permission and adolescent assent. Participants were asked to rate the risk categorization 
(using pediatric risk categories I to IV) of the scenario and to state whether they felt that the 
study was “IRB approvable,” in other words, that it met the regulatory requirements for 
research with children. We created an outcome variable consisting of a composite score 
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based on the correct risk classification and assessment of approvability. Correct risk 
categorization (risk category I, minimal risk) and approvability resulted in higher scores.
Forty-one percent of the respondents correctly identified the scenario as a risk 
category I, and 53% reported the study as described as approvable. The low 
proportion of participants who would approve the protocol suggests that 
participants may approach protection of adolescents from research harm by limiting 
access to research.
Predictor variables covered seven topics. Participants’ knowledge about minor health care 
consent laws and reporting requirements was measured using four items related to minor 
consent (concerning contraception, drug treatment, STI services, and emergency services) 
and three items related to reporting requirements on statutory rape, drug use, and child abuse 
(including sex between minors). Questions were based upon Indiana minor consent laws, 
child abuse laws, and Society for Adolescent Health and Medicine best practices for 
research with adolescents.12 Knowledge of federal pediatric research regulations was 
measured by three items (with Cronbach’s alpha = 0.76) covering the participants’ 
knowledge of Subpart D of the federal regulations, which covers research with children, and 
the report Research Involving Children from the National Commission for the Protection of 
Human Subjects of Biomedical and Behavioral Research.13 The most comprehensive and 
well-known guidelines for research with adolescents are those published by the Society for 
Adolescent Health and Medicine, and participants were asked about their knowledge of 
these.14 We also measured attitudinal factors that might affect review, including beliefs 
about adolescence (eight items, Cronbach’s alpha = 0.65; a sample item being “most 
adolescents are caring and altruistic) and religiosity and religious participation as measured 
by the Duke University Religion Index15 (5 items, Cronbach’s alpha = 0.89). Self-efficacy in 
reviewing adolescent sexual behavior protocols was measured with one item: “I find it 
challenging to assess risks and benefits of behavioral research with adolescents.”
Structural equation modeling (AMOS 21.0; all p < .05) was used to evaluate relationships 
between the outcome variable and predictors, including knowledge about laws, federal 
research guidelines, and opinions on the submission and approval process. The overall fit of 
the model was evaluated using the comparative fit index and root mean square error of 
approximation followed by a close examination of the significance values of each observed 
variable in the model. Only significant relationships were included in the final model.
Study Results
Respondents (n = 159) included 117 investigators, 68 IRB members, and 9 IRB staff 
members (with the possibility that participants held more than one of these roles). Over half 
(58%) were female, most were white (85.7%), and the average age was 46.7 (SD = 10.7). Of 
the IRB-member participants, 64% had served for five years or less, and 58% of IRB staff 
members had worked in the IRB office for under two years. Investigators included those 
who conducted research with adolescents as well as subspecialists such as pediatric 
oncologists and gastroenterologists whose research participants include adolescents. Forty-
one percent of the respondents correctly identified the scenario as a risk category I, and 53% 
reported the study as described as approvable. ANOVA results indicate no differences in risk 
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categorization or approvability between IRB staff members, IRB members, and investigators 
(F[2,156] = .402, p = NS; F[2,156] = .285, p = NS). Respondents who answered correctly 
about Indiana health care consent law for sexually transmitted disease diagnosis and 
treatment scored better on their overall assessment of the scenario’s risk category and 
approvability (β = .22). Respondents who knew that health care providers in their state do 
not need to report consensual sex between two 14-year-olds similarly scored better on their 
overall assessment of the scenario’s risk category and approvability (β =.12). However, 
beliefs that an adolescent in their state may consent for contraception services predicted 
lower scores (β = −.17). We note that Indiana does not have a minor consent law related to 
contraceptive use or family planning, and this ambiguity in the law may have meant that 
knowledgeable investigators were less likely to identify the scenario’s risk category 
correctly. We found no relationship between outcomes, risk categorization, and approvability 
with knowledge and beliefs about the following: health care consent laws for emergency 
services and drug treatment, reporting requirements on statutory rape and drug use, federal 
research regulations, Society for Adolescent Health and Medicine guidelines, and self-
efficacy in reviewing protocols. We additionally found no relationship between conservative 
beliefs about adolescents or the Duke Religion Index. The model showed good fit with a 
comparative fit index of .98 and a root mean square error of approximation of .067 (Figure 
1, available via the IRB: Ethics & Human Research web page).
Discussion
Less than 50% of study participants categorized the sample protocol as category 1, and just 
over 50% identified this lower risk protocol as IRB approvable. These findings are consistent 
with related research describing large variability in how IRB chairs would classify pediatric 
risk for a study of adolescent sexual behaviors.16 The low proportion of participants in our 
study who would approve the protocol suggests that participants may approach protection of 
adolescents from research harm by limiting access to research, a well-described tension in 
pediatrics.17 These findings highlight the need for IRBs to include members who are 
adolescent research specialists and for IRB members and staff members to obtain specialized 
training about ethical considerations related to adolescent sexual behavior research.
Greater understanding of the state minor consent laws and state mandatory reporting laws 
were the best predictors of appropriate risk categorization of a minimal risk protocol. This 
suggests that having legal and regulatory expertise specific to adolescent health may help 
facilitate the timely and appropriate review of protocols for research involving adolescents 
and sensitive topics. Given the apparent value of specific expertise and the lack of 
association between appropriate risk categorization and participants’ attitudes toward 
adolescence and religiosity, the findings also suggest that additional education of pediatric 
investigators and IRB members and staff members should concentrate on improving 
knowledge and appropriate application of relevant legal and clinical care guidelines, rather 
than on shifting intrinsic beliefs about adolescents and sensitive topics.
The study was limited to a single large institution in a Midwestern state that did not have a 
single pediatric IRB but, instead, reviewed pediatric protocols in IRBs with content-specific 
expertise (for example, oncology and behavioral health). Results thus may not be applicable 
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to institutions that have different IRB structures or that are in a different region. Further 
investigation into IRB decision-making would benefit greatly from qualitative data regarding 
how individual IRB members understand risk-benefit calculations as well as legal and 
clinical guidelines. Future research may seek to elucidate factors influencing IRB decisions 
about guardian waiver for adolescent sexual health research and about how IRB appraisals 
of risk and approvability may differ with studies with more complex methodologies as well 
as increases in real or perceived risk to adolescent subjects. Even with these limitations, this 
study adds to our understanding of how investigators and IRB members may make decisions 
about pediatric risk categorization and indicates how educational interventions may be 
improved.
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Figure 1. 
Path Analysis of Relationships between Knowledge and Risk Categorization and 
Approvability
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